Oncology header
Oncology

Nurturing your advancements in oncology

Discover – oncology solutions

Building towards precision medicine
A better understanding of molecular events underlying cancer progression drives advancements in oncology. Relevant biomarker detection is necessary to determine the optimal strategies in cancer prevention and care. However, identifying the right tools to make biomarker profiling effortless is challenging. Our comprehensive portfolio makes it easy for you to access valuable insights. From sample collection to data interpretation – we provide the most robust technologies and resources to help you detect, analyze and validate relevant biomarkers. We continuously strive to innovate and expand the range of solutions we offer, further paving the path to precision medicine. 

Tell us about yourself

Help us provide more of the content that you're looking for by selecting topics that interest you.

Tell us about yourself

Interests
Already have a My QIAGEN account? Sign in to see your saved interests

Latest insights
–
new solutions, events and more

The EMJ Podcast: Hope for NSCLC patients
The EMJ Podcast: Hope for NSCLC patients
Listen in as two experts, a clinician and a cancer survivor, share their perspectives on the changing landscape of targeted therapies for NSCLC.
Listen now
Global Oncohematology Summit: Sep 13 and 14
Global Oncohematology Summit: Sep 13 and 14
Ready to address challenges impacting blood cancer diagnosis and monitoring? Take the I Can pledge and join the event.
Count me in
Your partner in oncohematology
Your partner in oncohematology
We support your path to personalized blood cancer care and molecular research advancements with our comprehensive Sample to Insight solutions.
Learn more
Webinar: CDx commercialization
Webinar: CDx commercialization
Join three international experts in our live webinar and discover how to prepare for successful CDx commercialization. Learn how to set up CDx testing in time for drug launch and Day-One patient access.
Register now
The power of one
The power of one
Comprehensive genomic profiling (CGP) is dramatically changing our understanding of many cancers. Our multimodal technology can maximize insights by simultaneously preparing DNA and RNA libraries from a single total nucleic acid sample.
Find out more
Want to learn more about our oncology portfolio?
Our Sample to Insight solutions make it easy to access valuable biomarker information.
View products

Inspiration from the lab

Susan Branford ASCO 2018 cancer
Sue Branford, Head of the Leukaemia Lab in the Department of Genetics and Molecular Pathology, Centre for Cancer Biology at SA Pathology, Adelaide, South Australia
Sue Branford - A leading scientist
“Cancer touches many people at some stage during their lifetime and being involved in cancer research is a privilege and rewarding on many fronts. I have been fortunate that my research has translated into the clinic to directly benefit patients and influence management decisions.”

Professor Sue Branford is Head of the Leukaemia Lab in the Department of Genetics and Molecular Pathology at SA Pathology. She is a National Health and Medical Research Council Research Fellow and leads the International Chronic Myeloid Leukaemia Genomics Alliance. Learn about her journey and outstanding accolades, and her contributions to fighting blood cancer.

Learn more

In-focus
–
relevant biomarkers and molecular signatures

PIK3CA status matters
PIK3CA status matters
Want to detect actionable mutations in PIK3CA? Use our test to identify breast cancer patients that may be eligible for treatment with PIQRAY.
Explore now
Confidently detect FGFR mutations
Confidently detect FGFR mutations
Learn about our solution to confidently assess genomic alternations in the FGFR3 gene in bladder cancer.
Find out more

Testimonials from our global lab partners

Dr. Friedel Nollet, Molecular Biologist, Department of Laboratory Medicine
"The testing workflow also needed to be compatible with GC-rich genomic regions, providing 100% coverage of genes rich in GC content such as CEBPA. Accurate detection of large insertions/deletions and the internal tandem duplications (ITD) of the FLT3 gene is also a major faction for us. QIAseq panels were the optimal solution for all of these testing needs."

Dr. Friedel Nollet, Molecular Biologist, AZ Sint-Jan Brugge, Belgium

 

"The Quest/QIAGEN partnership has allowed us to provide rapid and insightful information to our clinical colleagues, allowing us to better take care of their patients."
"The Quest/QIAGEN partnership has allowed us to provide rapid and insightful information to our clinical colleagues, allowing us to better take care of their patients."
Dr. Frederick K. Rocke, Medical Director of Hematology/Oncology and Coogulation, Quest Diagnostics
"PIK3CA is the perfect example of how things should be done. All parties were optimally aligned to have the new test validated according to the very rigorous FDA standards."
"PIK3CA is the perfect example of how things should be done. All parties were optimally aligned to have the new test validated according to the very rigorous FDA standards."
Dr. Lawrence Weiss, Chief Medical Officer, NeoGenomics
Explore our Cancer Research Hub.
Accelerate your journey to insights and help conquer cancer.
Visit hub

Featured resources
–
information to support your work

Real-world lab experience
Real-world lab experience
Our scientists continue to find innovative oncohematology solutions supporting labs throughout the world. Read our real-world lab experience and get advice to overcome workflow challenges and maximize blood cancer insights with fewer resources.
Download flyer
Expert webinars at your fingertips
Expert webinars at your fingertips
Want advice to overcome typical workflow challenges? Access our on-demand webinars that reveal useful tips and tricks and advice from the experts. Learn how our NGS solutions were able to support their research.
Learn more
One simple workflow for lung cancer profiling
One simple workflow for lung cancer profiling
Want a panel to deliver comprehensive coverage of known and novel fusions as well as all relevant alterations? Our QIAseq Lung Multimodal Panel starts with total nucleic acids (DNA + RNA) and prepares targeted DNA and RNA libraries using a one-day, consolidated workflow.
Download flyer

Together, we’ll improve cancer care

Share your story using #TestCancer #TestYourPatients.

Every test matters. Every patient matters. Join us in improving biomarker testing and reducing the burden of cancer. Share your cancer story on social media using #TestCancer or #TestYourPatients. We’ll curate and display them on our social media wall here.